Interventions to improve delivery of isoniazid preventive therapy: an overview of systematic reviews

详细信息    查看全文

• 作者：Lisa V Adams (10)
  Elizabeth A Talbot (10)
  Karen Odato (11)
  Heather Blunt (11)
  Karen R Steingart (12)
  
  10. Infectious Disease and International Health Section ; Department of Medicine ; Geisel School of Medicine at Dartmouth ; 1 Rope Ferry Road ; Hanover ; NH ; 03755 ; USA
  11. Biomedical Libraries ; Geisel School of Medicine at Dartmouth ; 37 Dewey Field Road ; Hanover ; NH ; 03755 ; USA
  12. Cochrane Infectious Diseases Group ; Liverpool ; UK
  
• 关键词：Tuberculosis ; HIV ; Adherence ; Latent tuberculosis infection
• 刊名：BMC Infectious Diseases
• 出版年：2014
• 出版时间：December 2014
• 年：2014
• 卷：14
• 期：1
• 全文大小：465 KB
• 参考文献：1. Akolo, C, Adetifa, I, Shepperd, S, Volmink, J (2010) Treatment of latent tuberculosis infection in HIV infected persons. Cochrane Database Syst Rev 1: pp. CD000171
  2. Curry, FJ (1967) Prophylactic effect of isoniazid in young tuberculin reactors. N Engl J Med 277: pp. 562-567 CrossRef
  3. Hsu, KH (1974) Isoniazid in the prevention and treatment of tuberculosis. A 20-year study of the effectiveness in children. JAMA 229: pp. 528-533 CrossRef
  4. Mandalakas, AM, Hesseling, AC, Gie, RP, Schaaf, HS, Marais, BJ, Sinanovic, E (2013) Modelling the cost-effectiveness of strategies to prevent tuberculosis in child contacts in a high-burden setting. Thorax 68: pp. 247-255 CrossRef
  Guidance for national tuberculosis programmes on the management of tuberculosis in children 鈥?2nd ed. World Health Organization, Geneva
  5. van Wyk, SS, Reid, AJ, Mandalakas, AM, Enarson, DA, Beyers, N, Morrison, J, Hesseling, AC (2011) Operational challenges in managing Isoniazid Preventive Therapy in child contacts: a high-burden setting perspective. BMC Public Health 11: pp. 544 CrossRef
  6. Bristow, CC, Larson, E, Vilakazi-Nhlapo, AK, Wilson, M, Klausner, JD (2012) Scale-up of isoniazid preventive therapy in PEPFAR-assisted clinical sites in South Africa. Int J Tuberc Lung Dis 16: pp. 1020-1022 CrossRef
  7. Chehab, JC, Vilakazi-Nhlapo, K, Vranken, P, Peters, A, Klausner, JD (2012) Survey of isoniazid preventive therapy in South Africa, 2011. Int J Tuberc Lung Dis 16: pp. 903-907 CrossRef
  8. Lewin S, Munabi Babigumira S, Glenton C, Daniels K, Bosch Capblanch X, Van Wyk BE, Odgaard Jensen J, Johansen M, Aja GN, Zwarenstein M, Scheel IB: Lay health workers in primary and community health care for maternal and child health and the management of infectious diseases. / Cochrane Database Syst Rev 2010, (3):CD004015. doi:10.1002/14651858.CD004015.pub3
  9. Claxton, AJ, Cramer, J, Pierce, C (2001) A systematic review of the associations between dose regimens and medication compliance. Clin Ther 23: pp. 1296-1310 CrossRef
  10. Dodds, F, Rebair-Brown, A, Parsons, S (2000) A systematic review of randomized controlled trials that attempt to identify interventions that improve patient compliance with prescribed antipsychotic medication. Clin Effect Nurs 4: pp. 47-53 CrossRef
  11. Hampson, SE, Skinner, TC, Hart, J, Storey, L, Gage, H, Foxcroft, D, Kimber, A, Shaw, K, Walker, J (2001) Effects of educational and psychosocial interventions for adolescents with diabetes mellitus: a systematic review. Health Technol Assess 5: pp. 1-79
  12. Sharp, J, Wild, MR, Gumley, AI (2005) A systematic review of psychological interventions for the treatment of nonadherence to fluid-intake restrictions in people receiving hemodialysis. Am J Kidney Dis 45: pp. 15-27 CrossRef
  13. Vergouwen, AC, Bakker, A, Katon, WJ, Verheij, TJ, Koerselman, F (2003) Improving adherence to antidepressants: a systematic review of interventions. J Clin Psychiatry 64: pp. 1415-1420 CrossRef
  14. M鈥橧munya JM, Kredo T, Volmink J: Patient education and counselling for promoting adherence to treatment for tuberculosis. / Cochrane Database Syst Rev 2012, (5):CD006591. doi:10.1002/14651858.CD006591.pub2
  15. Lutge, EE, Wiysonge, CS, Knight, SE, Volmink, J (2012) Material incentives and enablers in the management of tuberculosis. Cochrane Database Syst Rev 1: pp. CD007952
  16. van Dulmen, S, Sluijs, E, van Dijk, L, de Ridder, D, Heerdink, R, Bensing, J (2007) Patient adherence to medical treatment: a review of reviews. BMC Health Serv Res 7: pp. 55 CrossRef
  17. / Cochrane Effective Practice and Organisation of Care Review Group, Data Collection Checklist. 2002. http://epoc.cochrane.org/sites/epoc.cochrane.org/files/uploads/datacollectionchecklist.pdf http://epoc.cochrane.org/sites/epoc.cochrane.org/files/uploads/datacollectionchecklist.pdf
  18. Smith, V, Devane, D, Begley, CM, Clarke, M (2011) Methodology in conducting a systematic review of systematic reviews of healthcare interventions. BMC Med Res Methodol 11: pp. 15 CrossRef
  19. Becker, LA, Oxman, AD Overviews of reviews. In: Higgins, JPT, Green, S eds. (2008) Cochrane Handbook for Systematic Reviews of Interventions.
  Guidelines for intensified tuberculosis case-finding and isoniazid preventive therapy for people living with HIV in resource-constrained settings. World Health Organization, Geneva
  Targeted tuberculin testing and treatment of latent tuberculosis infection. MMWR Recomm Rep 49: pp. 151
  20. Al-Darraji, HAA, Kamarulzaman, A, Altice, FL (2012) Isoniazid preventive therapy in correctional facilities: a systematic review. Int J Tuberc Lung Dis 16: pp. 871-879 CrossRef
  21. DeFulio, A, Silverman, K (2012) The use of incentives to reinforce medication adherence. Prev Med 55: pp. S86-S94 CrossRef
  22. Uyei, J, Coetzee, D, Macinko, J, Guttmacher, S (2011) Integrated delivery of HIV and tuberculosis services in sub-Saharan Africa: a systematic review. Lancet Infect Dis 11: pp. 855-867 CrossRef
  23. Hirsch-Moverman, Y, Daftary, A, Franks, J, Colson, PW (2008) Adherence to treatment for latent tuberculosis infection: systematic review of studies in the US and Canada. Int J Tuberc Lung Dis 12: pp. 1235-1254
  24. Zu帽iga, JA (2012) Medication adherence in Hispanics to latent tuberculosis treatment: a literature review. J Immigr Minor Health 14: pp. 23-29 CrossRef
  25. Hopkins, A, Solomon, J, Abelson, J (1996) Shifting boundaries in professional care. J R Soc Med 89: pp. 364-371
  26. Shea, BJ, Grimshaw, JM, Wells, GA, Boers, M, Andersson, N, Hamel, C, Porter, AC, Tugwell, P, Moher, D, Bouter, LM (2007) Development of AMSTAR: a measurement tool to assess the methodological quality of systematic reviews. BMC Med Res Methodol 7: pp. 10 CrossRef
  Global tuberculosis report 2013; WHO report. World Health Organization, Geneva
  27. Ryan R, Santesso N, Hill S, Lowe D, Kaufman C, Grimshaw J: Consumer-oriented interventions for evidence-based prescribing and medicines use: an overview of systematic reviews. / Cochrane Database Syst Rev 2011., (5): Art. No.: CD007768. doi:10.1002/14651858.CD007768.pub2
  28. The pre-publication history for this paper can be accessed here: http://www.biomedcentral.com/1471-2334/14/281/prepub
  
• 刊物主题：Infectious Diseases; Parasitology; Medical Microbiology; Tropical Medicine; Internal Medicine;
• 出版者：BioMed Central
• ISSN：1471-2334

文摘

Background Uptake of isoniazid preventive therapy (IPT) to prevent tuberculosis has been poor, particularly in the highest risk populations. Interventions to improve IPT delivery could promote implementation. The large number of existing systematic reviews on treatment adherence has made drawing conclusions a challenge. To provide decision makers with the evidence they need, we performed an overview of systematic reviews to compare different organizational interventions to improve IPT delivery as measured by treatment completion among those at highest risk for the development of TB disease, namely child contacts or HIV-infected individuals. Methods We searched the Cochrane Database of Systematic Reviews, the Database of Abstracts of Reviews of Effects (DARE), and MEDLINE up to August 15, 2012. Two authors used a standardized data extraction form and the AMSTAR instrument to independently assess each review. Results Six reviews met inclusion criteria. Interventions included changes in the setting/site of IPT delivery, use of quality monitoring mechanisms (e.g., directly observed therapy), IPT delivery integration into other healthcare services, and use of lay health workers. Most reviews reported a combination of outcomes related to IPT adherence and treatment completion rate but without a baseline or comparison rate. Generally, we found limited evidence to demonstrate that the studied interventions improved treatment completion. Conclusions While most of the interventions were not shown to improve IPT completion, integration of tuberculosis and HIV services yielded high treatment completion rates in some settings. The lack of data from high burden TB settings limits applicability. Further research to assess different IPT delivery interventions, including those that address barriers to care in at-risk populations, is urgently needed to identify the most effective practices for IPT delivery and TB control in high TB burden settings.